SNHG4 and endometrial cancer: To further understand the clinical relevance of SNHG4 expressions in endometrial cancer serum, we divided all 100 patients with high SNHG4 expression (n = 73) and patients with low SNHG4 expression (n = 27) (Supplementary Table S3).